• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Issues for interpreting external stakeholder feedback on restructuring NCIC's research programs.

作者信息

Ashbury F D, Iverson D C, Shephard P J

机构信息

Centre for Behavioural Research and Program Evaluation, NCIC, Toronto, Ontario.

出版信息

Can J Oncol. 1995 Mar;5(1):328-37.

PMID:8853475
Abstract

The National Cancer Institute of Canada surveyed members of its stakeholder groups on a number of issues pertaining to restructuring research programs. While it was hoped that the survey would ensure input from its primary stakeholder groups and thereby facilitate decision-making on critical issues like distribution of funds and research awards, there is reason to believe this may not have occurred. Some of the stakeholder groups seemed to be over-represented in the respondent population and the effect of this on the results was therefore examined. Analysis revealed several important issues: 1) a clear definition of who constitutes a "stakeholder" needs to be developed when stakeholder input-gathering is being contemplated; 2) multi-faceted strategies need to be developed to gain input from stakeholders; 3) potential sources of bias can emerge from the various techniques used to gather feedback from stakeholders; and 4) a clear outline of how the feedback is to be used in the decision-making process needs to be determined.

摘要

相似文献

1
Issues for interpreting external stakeholder feedback on restructuring NCIC's research programs.
Can J Oncol. 1995 Mar;5(1):328-37.
2
Charting the NCIC's future: stakeholder support for identified options.
Can J Oncol. 1995 Mar;5(1):314-27.
3
Restructuring of NCIC research programs National Cancer Institute of Canada, Toronto, Ontario.加拿大安大略省多伦多市加拿大国家癌症研究所NCIC研究项目的重组
Can J Oncol. 1995 Mar;5(1):307-13.
4
Restructuring: meeting the challenges.重组:应对挑战。
Can J Oncol. 1995 Mar;5(1):VII-IX.
5
Procedures and methods of benefit assessments for medicines in Germany.德国药品效益评估的程序和方法。
Eur J Health Econ. 2008 Nov;9 Suppl 1:5-29. doi: 10.1007/s10198-008-0122-5.
6
The role of lay panelists on grant review panels.非专业评审小组成员在资助评审小组中的作用。
Chronic Dis Can. 2003 Spring-Summer;24(2-3):70-4.
7
[Procedures and methods of benefit assessments for medicines in Germany].[德国药品效益评估的程序和方法]
Dtsch Med Wochenschr. 2008 Dec;133 Suppl 7:S225-46. doi: 10.1055/s-0028-1100954. Epub 2008 Nov 25.
8
National health research system mapping in 10 Eastern Mediterranean countries.东地中海10个国家的国家卫生研究系统测绘
East Mediterr Health J. 2008 May-Jun;14(3):502-17.
9
The NCI All Ireland Cancer Conference.美国国家癌症研究所全爱尔兰癌症会议。
Oncologist. 1999;4(4):275-277.
10
Stakeholder research on biospecimen needs and reactions to the development of a national cancer human biobank by the National Cancer Institute.美国国立癌症研究所关于生物样本需求以及对国家癌症人类生物样本库发展的反应的利益相关者研究。
J Natl Cancer Inst Monogr. 2011;2011(42):16-23. doi: 10.1093/jncimonographs/lgr008.